| Date Filed | Type | Description |
| 10/02/2023 |
4
| Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 827 shares
@ $15.87, valued at
$13.1k
|
|
| 07/05/2023 |
4
| Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 695 shares
@ $18.87, valued at
$13.1k
|
|
| 06/16/2023 |
4
| Arbuckle Stuart A (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 13,090 restricted stock units
@ $0
Granted 19,597 options to buy
@ $0 |
|
| 06/01/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 82 shares
@ $329.82, valued at
$27k
|
|
| 02/28/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 4,714 shares
@ $289.12, valued at
$1.4M
Sold 3,834 shares
@ $287.16, valued at
$1.1M
Sold 400 shares
@ $287.59, valued at
$115k
Sold 800 shares
@ $288.92, valued at
$231.1k
|
|
| 02/24/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 129 shares
@ $291.84, valued at
$37.6k
Sold 300 shares
@ $292.86, valued at
$87.9k
Sold 1,378 shares
@ $294.29, valued at
$405.5k
Sold 394 shares
@ $295.38, valued at
$116.4k
Sold 200 shares
@ $296.31, valued at
$59.3k
|
|
| 02/22/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 4,498 shares
@ $292.85, valued at
$1.3M
Sold 21 shares
@ $291.01, valued at
$6.1k
Sold 545 shares
@ $292.77, valued at
$159.6k
Sold 1,100 shares
@ $293.74, valued at
$323.1k
Sold 736 shares
@ $294.58, valued at
$216.8k
|
|
| 02/14/2023 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,372 shares
@ $294.33, valued at
$992.5k
Paid exercise price by delivering 5,990 shares
@ $298.26, valued at
$1.8M
Sold 245 shares
@ $296.44, valued at
$72.6k
Sold 2,028 shares
@ $298.42, valued at
$605.2k
Sold 1,779 shares
@ $299.26, valued at
$532.4k
Sold 835 shares
@ $300.13, valued at
$250.6k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,040 shares
@ $237.74, valued at
$722.7k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2 shares
@ $186.99, valued at
$374
Sold 1 shares
@ $187.8, valued at
$187.8 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Arbuckle Stuart A (EVP, Chief Commercial Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2 shares
@ $222.47, valued at
$444.9
Sold 5 shares
@ $224.11, valued at
$1.1k
|
|
| 11/05/2020 |
4
| Arbuckle Stuart A (EVP, Chief Commercial Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 487 shares
@ $210.56, valued at
$102.5k
Sold 487 shares
@ $211.54, valued at
$103k
Sold 245 shares
@ $212.38, valued at
$52k
Sold 334 shares
@ $214.13, valued at
$71.5k
Exercised 1,553 options to buy
@ $86.52, valued at
$134.4k
|
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|